Today: 9 June 2026
Browse Category

NYSE:GEV 23 January 2026 - 4 March 2026

GE Vernova stock edges higher after Italy wind order and $30 million grid plant expansion

GE Vernova stock edges higher after Italy wind order and $30 million grid plant expansion

GE Vernova shares rose 0.8% to $848.76 after announcing new wind and grid equipment deals in Italy, including 17 turbines for IVPC Group’s Fortore wind farm. The company will invest $30 million to expand its Milan-area plant, adding 50 jobs. GE Vernova also closed the $600 million sale of its Proficy software unit to TPG. Equipment shortages and labor constraints continue to affect project timelines.
4 March 2026
···
GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next

GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next

GE Vernova shares closed at $873.60 Friday, down 0.33%, after trading between $853.34 and $876.36. The Dow fell 1.05%, S&P 500 lost 0.43%, and Nasdaq dropped 0.92% as U.S. wholesale inflation rose 0.5% in January. GE Vernova warned in January that turbine installation delays at Vineyard Wind could cut revenue and lead to $400 million in losses. The next U.S. jobs report is due March 6.
28 February 2026
··
GE Vernova (GEV) stock tumbles 7% as bond sale settles, even with a fresh Baird upgrade

GE Vernova (GEV) stock tumbles 7% as bond sale settles, even with a fresh Baird upgrade

GE Vernova shares fell 6.6% to $729.05 by midday Wednesday after a streak of record highs, following news of a $2.6 billion bond sale to fund its $5.3 billion Prolec GE acquisition. The stock swung between $728 and $797. Baird upgraded the stock, while Xcel Energy and GE Vernova announced a major turbine and wind project alliance. The company’s wind segment reported a $598 million EBITDA loss for 2025.
4 February 2026
··
GE Vernova stock price hits new high as Prolec GE buyout closes and bond sale starts

GE Vernova stock price hits new high as Prolec GE buyout closes and bond sale starts

GE Vernova closed its $5.28 billion purchase of the remaining Prolec GE stake from Xignux and launched a senior notes offering to help fund the deal. Shares rose 4% to $754.97, holding steady after hours. Fitch and S&P rated the planned debt investment grade. The company’s wind segment reported a $598 million loss for 2025 and expects further losses in 2026.
3 February 2026
···
GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova stock rises as senior notes offering targets Prolec GE deal

GE Vernova shares rose 3.6% to $752.44 Monday after launching a senior notes offering to help fund its $5.3 billion acquisition of the remaining Prolec GE stake. The company has not disclosed the size or maturity of the bonds. Proceeds will also support general corporate needs. Investors are watching for pricing details and confirmation the Prolec deal closes as scheduled.
2 February 2026
···
GE Vernova stock price: GEV ends week higher as wind risks shadow next session

GE Vernova stock price: GEV ends week higher as wind risks shadow next session

GE Vernova shares closed Friday at $726.37, up 1.3%, after touching $752 intraday and rising 9% for the week. The company raised its 2026 revenue forecast to up to $45 billion and projected wind segment EBITDA losses of about $400 million. Fourth-quarter orders hit $22.2 billion, with a backlog of $150 billion. Missing 11 turbines at Vineyard Wind could cut revenue by over $400 million.
31 January 2026
··
GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova stock price rises after outlook raise; traders eye Feb. 2 Prolec close

GE Vernova shares closed up 1.25% at $726.37 Friday, hitting an intraday high of $752.02 before slipping 0.2% after hours. The company warned Vineyard Wind delays could cut $250 million from wind revenue and trigger $400 million in losses if 11 turbines aren’t installed. GE Vernova expects 2026 revenue of $44–$45 billion, above analyst forecasts. The Prolec GE acquisition is set to close Feb. 2.
31 January 2026
··
GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary

GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary

GE Vernova shares rose 0.9% to $723.87 Friday after the company raised its 2026 revenue and cash flow forecasts, citing strong turbine and grid demand. The company warned delays at its Vineyard Wind project could cut 2026 revenue by $250 million and deepen losses if more turbines remain uninstalled. Fourth-quarter results showed $11 billion in revenue and $1.8 billion in free cash flow.
30 January 2026
··
GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova shares rose 1.7% to $669.04 Monday afternoon ahead of its quarterly earnings report, due before markets open Jan. 28. Morgan Stanley maintained an Overweight rating but lowered its price target to $817. Wall Street expects earnings of $3.03 per share on $10.04 billion revenue. The report coincides with the Federal Reserve’s policy decision Wednesday.
26 January 2026
··
GE Vernova stock price: GEV heads into Jan. 28 earnings after a Friday dip

GE Vernova stock price: GEV heads into Jan. 28 earnings after a Friday dip

GE Vernova shares closed at $657.78 Friday, down 0.6% for the day and 3.5% for the week. The company reports quarterly results Wednesday, Jan. 28, before the U.S. market opens. Investors are watching demand for gas turbines, grid equipment, and cash flow outlooks. Eric Gray will replace Mavi Zingoni as Power segment CEO, with Zingoni staying as adviser until June 30.
25 January 2026
··
1 2 3 … 5

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop